Close
CDMO Safety Testing 2026
Novotech

Tag: Pharmaceuticals

CordenPharma Seals AmbioPharm Deal to Expand Global Network

CordenPharma, a global contract development and manufacturing organization specializing in complex drug modalities, has officially entered into an agreement to acquire AmbioPharm. The AmbioPharm...

Shilpa Biologicals Urges Stronger CDMO Selection Strategy

Ahead of BIO San Diego next month, Shilpa Biologicals has called on emerging biotech companies to rethink how they approach CDMO Selection as investment...

MSD and Adcendo Initiate Phase Ib Collaboration for Solid Tumours

MSD and Adcendo have established a collaboration and supply agreement to evaluate the combination of ADCE-T02 and pembrolizumab. The companies are preparing for a...

Chemspec Europe 2026 Draws Global Industry Participation

Chemspec Europe returned to Cologne on 6โ€“7 May 2026, bringing together professionals from across the speciality chemicals sector despite ongoing economic and regulatory challenges...

Eli Lilly Returns to Infectious Disease with $3.8 Billion Acquisition Strategy

After a seven-year absence from the sector, Eli Lilly is returning to the field through a trio of corporate purchases valued at more than...

Bristol Myers Squibb Integrates AI to Advance Manufacturing Quality Systems

Bristol Myers Squibb has entered into a strategic agreement with Anthropic to deploy its Claude platform across global operations. This initiative moves beyond standard...

Angelini Pharma Expands US Presence with Catalyst Pharmaceuticals Acquisition

Angelini Pharma has finalized a definitive agreement to acquire Catalyst Pharmaceuticals for an equity value of approximately โ‚ฌ3.5bn ($4.1bn). This move marks a strategic...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read

Translate ยป